ORIGINAL RESEARCH

Prediction of bacterial vulvovaginitis in girls at different Tanner stages of sexual development

About authors

1 Samara State Medical University, Samara, Russia

2 Kulakov Federal Research Center for Obstetrics, Gynecology, and Perinatolоgy, Moscow, Russia

Correspondence should be addressed: Anna V. Kazakova
Lesnaya 31, kv. 40, Samara, 443110; ur.xednay@08912041ogima

About paper

Author contribution: Kazakova AV — study concept and design, data acquisition and analysis, manuscript draft; Uvarova EV — study concept and design, manuscript revision; Limareva LV — study concept and design, manuscript revision; Trupakova AA, Mishina AI — data acquisition and analysis, manuscript draft.

Received: 2019-09-27 Accepted: 2019-10-17 Published online: 2019-10-29
|
  1. Alvarez-Olmos MI, et al. Vaginal lactobacilli in adolescent: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex Transm Dis. 2004; (31): 393–400.
  2. Amjadi F, et al. Role of the innate immunity in female reproductive tract. Adv Biomed Res. 2014; (3): 1.
  3. Attieh E, Maalouf S, Roumieh D, et al. Feminine hygiene practices among female patients and nurses in Lebanon. Reproductive Health. 2016; 13 (1): 59.
  4. Beyiter I, Kavukcu S. Clinical presentation, diagnosis and treatment of vulvovaginitis in girls: a current approach and review of the literature. World J Pediatr. 2017; 13 (2): 101–5.
  5. Kazakova A. V. Programma profilaktiki bakterial'nogo vul'vovaginita u devochek v zavisimosti ot stadii polovogo razvitija [dissertacija]. Samara, 2019. Russian.
  6. Prilepskaya VN, Letunovskaya AB, Donnikov AE. Mikrobiocenoz vlagalishha i polimorfizm genov citokinov kak marker zdorov'ja zhenshhiny. Ginekologija. 2015; (2): 4–13. Russian.
  7. Altun I, Cinar ND, Dede C. Hygiene behaviour in university students in Turkey. J Pak Med Assoc. 2013; 63 (5): 585–9.
  8. Grinevich EV. Harakteristika mikrobiocenozov vlagalishha, kishechnika i mochevyvodjashhih putej pri vul'vovaginitah u devochek rannego vozrasta v zavisimosti ot razlichnyh faktorov riska [dissertacija]. Smolensk, 2005. Russian.
  9. Kazakova AV, Spiridonova NV, Uvarova EV, Komarova MV, Bezrukova AA. Mnogomernyj analiz prediktorov patologicheskih vydelenij iz polovyh putej v zavisimosti ot obraza zhizni studentok. Reproduktivnoe zdorov'e detej i podrostkov. 2016; (6): 90–7. Russian.
  10. Chebotareva YuYu, Kostoeva ZA, Grigorjan AA. Anatomo-funkcional'nye osobennosti reproduktivnoj sistemy pri vul'vovaginitah u chasto bolejushhih detej. Kubanskij nauchnyj medicinskij vestnik. 2013; (1): 178–81. Russian.
  11. Karlsson CL, Molin G, Cilio CM, et al. The pioneer gut microbiota in human neonates vaginally born at terma pilot study. Pediatr Res. 2011; (70): 282–6.
  12. Kayserova J, et al. Serum immunoglobulin free light chains in severe forms of atopic dermatitis. Clin Immunol. 2010; (71): 312–6.
  13. Kestřánek J, Jílek P, Matula V, et al. Jaký je aktuální stav diagnostiky vulvovaginálního dyskomfortu v České Republice? Česká Gynekologie. 2013; 78 (6): 522–7.
  14. Mitchell C, Moreira C, Fredricks D, et al. Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis. Infectious Diseases in Obstetrics and Gynecology. 2009; (12) Access mode: https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC2777244/. (Date of access: 22.10.19).
  15. Zhizhko EV, Chiganovoj SD. Molodaja sem'ja: problemy i perspektivy social'noj podderzhki. Krasnojarsk: RUMC JuO, 2011; 145 s. Russian.
  16. Fischer GO. Chronic vulvitis in prepubertal girls. Aust J Dermatology. 2010; (51): 118–23.
  17. Lewis WG, Robinson LS, Perry J, et al. Hydrolysis of secreted sialoglycoprotein immunoglobulin A (IgA) in ex vivo and biochemical models of bacterial vaginosis. J Biol Chem. 2012; 287 (3): 2079–89.
  18. Ott MA, Ofner S, Fortenberry JD. Beyond douching: use of feminine hygiene products and STI risk among young women. J Sex Med. 2009; (6): 1335–40.
  19. Kohreidze NA, Gurkin YuA, Kutusheva GF, i dr. Vul'vovaginit v rannem detstve. SPb., 2017; 23 s. Russian.
  20. Zijadullaev UH. Sostojanie immuniteta pri kandidoznom vul'vovaginite u devochek podrostkov. Problemy reprodukcii. 2014; (2): 32–4. Russian.
  21. Gardner MJ, Altman DG. Statistics with confidence. BMJ publications. Reprint. 1994: 51–52.
  22. Bjerre LM, LeLorier J. Expressing the magnitude of adverse effects in case-control studies: “the number of patients needed to be treated for one additional patient to be harmed”. BMJ. 2000; (320): 503–6.
  23. Zdravoohranenie v Rossii. 2017: Statisticheskij sb. Rosstat. Moskva, 2017; 170 s. Dostupno po ssylke: [http://www.gks.ru/ free_doc/doc_2017/zdrav17.pdf]. Russian.
  24. Kirillova EN, Pavlyukova SA, Akulich NS. Vul'vovaginit u detej. Medicinskij zhurnal. 2017; (2): 151–3. Russian.
  25. Brabin L, Roberts SA, Fairbrother E, et al. Factors affecting vaginal pH levels among female adolescents attending genitourinary medicine clinics. Sex Transm Infect. 2005; (81): 483–7.
  26. Brotman RM, Erbelding EJ, Jamshidi RM, et al. Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics. J Pediatr Adolesc Gynecol. 2007; (20): 225–31.
  27. Donders GG, et al. Vaginal cytokines in normal pregnancy. American journal of obstetrics and gynecology. 2003; (189): 1433–8.